Literature DB >> 19956854

Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.

Kun Zhang1, Yong-Qing Zhou, Hang-Ping Yao, Ming-Hai Wang.   

Abstract

Cell migration followed by matrix invasion is a critical step required for epithelial cell differentiation, growth and survival. This study determined the RON receptor in regulation of motile-invasive phenotypes of epithelial cells. Two RON variants, RON165.e11p and RON165, with alterations in a defined extracellular domain were used as the model. RON165 is a splicing variant generated by an mRNA transcript with an in-frame deletion of 49 amino acids encoded by exon 11. In contrast, RON165.e11p was produced by a partial deletion of exon 11 with the elimination of the first 40 amino acids. Thus, RON165.e11p differs from RON165 with nine amino acids retained in the fourth immunoglobulin-plexin-transcription (IPT) domain. Biochemically, both RON165 and RON165.e11p exist as a single-chain protein, residing in the cytoplasm, and failed to mature into the two-chain receptor. Both RON165 and RON165.e11p spontaneously formed oligomers in vivo leading to constitutive phosphorylation and the activation of downstream signaling proteins. Although lacking cell-transforming activities, RON165 and RON165.e11p mediated the epithelial to mesenchymal transition with spindle-like cell morphologies, diminished E-cadherin expression, and increased N-cadherin and vimentin expression. These changes facilitated epithelial cell migration and invasion as modeled in Martin-Darby canine kidney (MDCK) cells. Moreover, expression of RON165 or RON165.e11p in breast epithelial MCF-7 cells diminished epithelial cell phenotypes and increased motile and invasive activities. Thus, alterations in the defined extracellular region result in two unique RON variants with similar biological properties. The ability of RON165 or RON165.e11p to promote motile-invasive phenotypes may represent a mechanism by which RON regulates epithelial cell phenotypes and biological activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956854

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

Review 1.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 2.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

Review 3.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 4.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

5.  Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.

Authors:  Qi Ma; Kun Zhang; Sunny Guin; Yong-Qing Zhou; Ming-Hai Wang
Journal:  Mol Cancer       Date:  2010-11-29       Impact factor: 27.401

6.  The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Qi Ma; Sunny Guin; Snehal S Padhye; Rui-Wen Zhang; Ming-Hai Wang
Journal:  Mol Cancer       Date:  2011-07-12       Impact factor: 27.401

7.  Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines.

Authors:  Dong-Hui Zhou; Chao Li; Li-Na Yang
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

8.  Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.

Authors:  Simon Braun; Mihaela Enculescu; Samarth T Setty; Mariela Cortés-López; Bernardo P de Almeida; F X Reymond Sutandy; Laura Schulz; Anke Busch; Markus Seiler; Stefanie Ebersberger; Nuno L Barbosa-Morais; Stefan Legewie; Julian König; Kathi Zarnack
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

Review 9.  Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction.

Authors:  Ming-Hai Wang; Ruiwen Zhang; Yong-Qing Zhou; Hang-Ping Yao
Journal:  J Biomed Res       Date:  2013-07-30

Review 10.  Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression.

Authors:  Sung Yeul Yang; Thi Thinh Nguyen; Trong Thuan Ung; Young Do Jung
Journal:  Chonnam Med J       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.